 Cardiac epinephrine synthesis Regulation glucocorticoid BACKGROUND heart epinephrine Homogenates rat heart enzymes N-methyltransferase PNMT nonspecific N-methyltransferase NMT methylate norepinephrine epinephrine cardiac atrium PNMT cardiac ventricle PNMT NMT METHODS RESULTS glucocorticoid dexamethasone doses mg/kg hours cardiac atria ventricle skeletal muscle adrenal increases PNMT activity much baseline NMT activity unchanged Longer-term treatment mg/kg dexamethasone daily days cardiac PNMT activity fivefold atrial epinephrine levels Dexamethasone ventricular epinephrine levels increased levels PNMT catechol-O-methyltransferase major catabolic enzyme epinephrine dexamethasone treatment volumes anti-PNMT antiserum PNMT enzymatic activity dexamethasone treatment amounts PNMT PNMT molecules Denervation masseter muscle rats unilateral superior cervical ganglionectomy tissue norepinephrine epinephrine levels effect masseter PNMT NMT levels chemical sympathectomy increases PNMT levels findings PNMT extraneuronal enzyme cardiac skeletal muscle CONCLUSIONS Glucocorticoids several cardiovascular effects increased cardiac output blood pressure Enhanced cardiac epinephrine synthesis glucocorticoid effects